Answers are grounded in this paper and cite their sources.
Introduction-Xerosis is a common skin condition affecting all skin types at all ages.However, itis somewhat more often observed in young children and the elderly.Objective-To assess the safety and benefit of a dermocosmetic balm in the management of xerosis.Methods-Non-interventional, non-comparative, prospective multicenter study conducted in xerosis subjects of at least 3 months of age.Clinical assessments included the investigator's evaluation of local tolerance, xerosis signs and symptoms at Days0, 14 and 21, as well as the subject's perception of improvement, satisfaction, and compliance.Results-The mean age of the 1149 recruited subjects was 42.4±24.9years.According to the investigators, 882 (76.8%) subjects had severe xerosis.The local tolerance of SBT was excellent, with only 1% of the subjects reporting adverse events leading to withdrawal.All xerosis signs and symptoms had significantly (p < 0.0001) improved at all post-Day 0 visits, starting as early as Day 7.Xerosis had improved in 1127 (98.1%) subjects and in 864 (75.2%) subjects the disorder had completely disappeared.Patient perception improved significantly (all p<0.0001) between Day 7 and Day 14/21 as well as between Day 14 and 21.In total, 1081 (94.1%) subjects rated the efficacy of the dermocosmetic excellent or good, and 1032 (91.2%) subjects were satisfied with the balm.Conclusion-The local tolerance of the balm is excellent.The balm provides good clinical benefit in the management of xerosis.
No takes yet. Share an insight, caveat, or question.
A 2017 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: